stockrowMyriad Genetics, Inc. (MYGN) vs Personalis, Inc. (PSNL)
- Myriad Genetics, Inc. MYGN 6.10 −3.02%
- Personalis, Inc. PSNL 15.65 +0.64%
Myriad Genetics, Inc. and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $601.6M — 2.8× the size. Personalis, Inc. grew revenue faster over the last twelve months: 16.9% against −3.16%. Myriad Genetics, Inc. has the higher net margin (−14.0% vs −147.7%) and the higher return on invested capital (−19.9% vs −358.4%). Across the 18 metrics below, Myriad Genetics, Inc. leads on 13 and Personalis, Inc. on 5.
Valuation
Profitability
| Metric | MYGN | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 68.83% | 16.71% | 48.32% |
| Operating margin | (12.22%) | (156.66%) | (5.68%) |
| Net margin | (13.96%) | (147.74%) | (4.10%) |
| Free cash flow margin | (1.76%) | (120.79%) | 0.00% |
| Return on equity | (32.54%) | (62.14%) | 0.00% |
| Return on assets | (17.11%) | (44.66%) | (6.05%) |
| Return on invested capital | (19.92%) | (358.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack